TC Biopharm () (TCBPW)
undefined
undefined%
At close: undefined
0.01
0.00%
After-hours Dec 13, 2024, 03:18 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - 3.84M 1.98M 1.98M 3.43M
Cost of Revenue - - - - -
Gross Profit - 3.84M 1.98M 1.98M 3.43M
Operating Income -14.24M -12.08M -7.29M -6.89M -6.64M
Interest Income 83.03K 6.75M 3.44M 291.03K 253.51K
Pretax Income -7.00M -3.03M -14.98M -6.63M -6.89M
Net Income -5.91M -1.31M -13.58M -5.46M -6.07M
Selling & General & Admin 6.87M 8.74M 3.11M 2.21M 3.01M
Research & Development 7.77M 7.59M 6.16M 6.68M 8.61M
Other Expenses - - - - -
Operating Expenses 6.91M 124.90K 13.52M 8.32M 10.07M
Interest Expense - 6.75M 3.44M 292.06K 275.41K
Selling & Marketing Expenses 402.31K 402.31K - - -
Cost & Expenses 6.91M 124.90K 13.52M 8.32M 10.07M
Income Tax -1.09M 1.72M 1.41M 1.17M 826.07K
Shares Outstanding (Basic) 30.89K 3.44K 1.95K 1.89K 1.89K
Shares Outstanding (Diluted) 30.89K 3.44K 1.95K 1.89K 1.89K
EPS (Basic) -191.21 -382.31 -6.95K -2.88K -
EPS (Diluted) -191.21 -382.31 -6.95K -2.88K -
EBITDA -13.61M -11.32M -6.48M -5.26M -5.92M
Depreciation & Amortization 630.06K 762.47K 811.96K 878.64K 721.93K